JP2024524572A5 - - Google Patents

Info

Publication number
JP2024524572A5
JP2024524572A5 JP2024500373A JP2024500373A JP2024524572A5 JP 2024524572 A5 JP2024524572 A5 JP 2024524572A5 JP 2024500373 A JP2024500373 A JP 2024500373A JP 2024500373 A JP2024500373 A JP 2024500373A JP 2024524572 A5 JP2024524572 A5 JP 2024524572A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
pharmaceutically acceptable
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024500373A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524572A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/056329 external-priority patent/WO2023281455A1/en
Publication of JP2024524572A publication Critical patent/JP2024524572A/ja
Publication of JP2024524572A5 publication Critical patent/JP2024524572A5/ja
Pending legal-status Critical Current

Links

JP2024500373A 2021-07-08 2022-07-08 クリオピリン関連周期性症候群(caps)のための処置 Pending JP2024524572A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202121030625 2021-07-08
IN202121030625 2021-07-08
PCT/IB2022/056329 WO2023281455A1 (en) 2021-07-08 2022-07-08 Treatment for cryopyrin associated periodic syndromes (caps)

Publications (2)

Publication Number Publication Date
JP2024524572A JP2024524572A (ja) 2024-07-05
JP2024524572A5 true JP2024524572A5 (cg-RX-API-DMAC7.html) 2025-07-17

Family

ID=84801366

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024500373A Pending JP2024524572A (ja) 2021-07-08 2022-07-08 クリオピリン関連周期性症候群(caps)のための処置

Country Status (7)

Country Link
US (1) US20250041267A1 (cg-RX-API-DMAC7.html)
EP (1) EP4366832A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024524572A (cg-RX-API-DMAC7.html)
CN (1) CN117940126A (cg-RX-API-DMAC7.html)
AU (1) AU2022305809A1 (cg-RX-API-DMAC7.html)
CA (1) CA3226058A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023281455A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4110058A4 (en) * 2020-02-28 2024-03-20 Zydus Lifesciences Limited Novel substituted sulfonylurea and sulfoximineurea derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3634951B8 (en) * 2017-06-09 2024-08-21 Zydus Lifesciences Limited Novel substituted sulfoximine compounds
CN120208846A (zh) * 2019-01-14 2025-06-27 载度思生命科学有限公司 经取代的磺酰脲类衍生物

Similar Documents

Publication Publication Date Title
JP2024532303A5 (cg-RX-API-DMAC7.html)
US20120093738A1 (en) Taste-masked oral formulations of influenza antivirals
RU2016122609A (ru) Составы соединений азаиндола
IL308744B1 (en) Compositions for use in increasing efficiency of cardiac metabolism
JP2011508768A (ja) パラセタモール及びイブプロフェンを含む医薬用経口懸濁剤
SI3082773T1 (en) Oral formulations of pyrrolidine derivatives
JPWO2009099132A1 (ja) グルタチオンの保存安定性向上方法
JP2024509820A5 (cg-RX-API-DMAC7.html)
KR20190092481A (ko) 은 및 셀레늄을 포함하는 항생제 조성물
JP2024524572A5 (cg-RX-API-DMAC7.html)
US20230346817A1 (en) Composition and use of sglt-2 inhibitor and angiotensin receptor blockers
WO2012027972A1 (zh) 富马酸替诺福韦酯α晶型及其制备方法和应用
DK2555776T3 (en) Combination Compositions of Adenosine A1 Agonists and Non-Selective Beta-Adrenoreceptor Blockers to Reduce Intraocular Pressure
CN103655555B (zh) 3-正丁基-异吲哚啉-1-酮在制备预防和治疗脑梗塞的药物中的应用
JP2010270140A (ja) ロキソプロフェン含有経口用組成物
EP1603550B1 (en) Pharmaceutical composition comprising 5-methyl-2-2'-(chloro-6'-fluoroanilino)phenylacetic acid
RU2010103934A (ru) Стабильная фармацевтическая композиция, содержащая водорастворимую соль винфлунина
CN105693715A (zh) 一种二乙酰大黄酸小檗碱偶合物的制备及医药用途
JP2022502448A5 (cg-RX-API-DMAC7.html)
KR100990223B1 (ko) 세프디니르의 용출속도를 개선한 약제학적 조성물
US20170312224A1 (en) Extended release formulations of flurbiprofen and tramadol
JP2024529185A5 (cg-RX-API-DMAC7.html)
US20170312236A1 (en) Pharmaceutical compositions of flurbiprofen and tramadol
CN105732608A (zh) 一种沙星类小檗碱偶合物制备方法及其医药用途
RU2025133530A (ru) Лечение бокового амиотрофического склероза (бас)